Corporate News     29-Jan-25
Sudarshan Chemical Industries allots 74.76 lakh equity shares under QIP issue
Sudarshan Chemical Industries has allotted 74,76,635 equity shares to eligible qualified institutional buyers at the issue price of Rs 1,070 per equity share (including a premium of ₹ 1,068 per equity share, (which includes a discount of ₹ 37.89 i.e., 3.42% of the floor price, as determined in terms of SEBI ICDR Regulations), aggregating to Rs 799.99 crore, pursuant to the QIP issue.
Previous News
  Sudarshan Chemical Industries to table results
 ( Corporate News - 05-Feb-25   11:13 )
  Sudarshan Chemical to acquire Germany-based Heubach Group
 ( Corporate News - 11-Oct-24   19:14 )
  Sudarshan Chemical Industries schedules board meeting
 ( Corporate News - 02-Dec-24   15:23 )
  Sudarshan Chemical Industries schedules board meeting
 ( Corporate News - 18-Jul-24   10:13 )
  Sudarshan Chemical Industries allots 18.69 lakh equity shares
 ( Corporate News - 13-Jan-25   19:49 )
  Sudarshan Chemical hits life high after arm inks pact to acquire Heubach Group’s pigment biz
 ( Hot Pursuit - 11-Oct-24   15:39 )
  Sudarshan Chemical Industries to hold board meeting
 ( Corporate News - 14-Oct-24   09:35 )
  Sudarshan Chemical Inds soars after Q4 PAT zooms to Rs 32 cr
 ( Hot Pursuit - 24-May-23   12:58 )
  Sudarshan Chemical Industries Ltd leads gainers in 'A' group
 ( Hot Pursuit - 24-May-23   12:00 )
  Volumes soar at Mahanagar Gas Ltd counter
 ( Hot Pursuit - 08-Aug-22   11:00 )
  Sudarshan Chemical
 ( Results - Analysis 13-Aug-20   15:43 )
Other Stories
  LMW schedules board meeting
  03-Jul-25   09:15
  Julien Agro Infratech announces board meeting date
  03-Jul-25   09:15
  Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
  03-Jul-25   09:15
  Shriram Asset Mgt. Company schedules AGM
  03-Jul-25   09:14
  Ideaforge Technology to convene AGM
  03-Jul-25   09:14
  D-Link (India) to announce Quarterly Result
  03-Jul-25   09:14
  Tuni Textile Mills to conduct board meeting
  03-Jul-25   09:14
  Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
  03-Jul-25   09:12
  Shakti Pumps launches QIP issue
  03-Jul-25   09:08
  Jai Mata Glass to conduct board meeting
  02-Jul-25   19:12
Back Top